Human genetics has been instrumental in identification of genetic variants linked to type 2 diabetes (T2D). Recently a rare, putative loss-of-function mutation in the orphan G-protein coupled receptor 151 (GPR151) was found to be associated with lower odds ratio for T2D, but the mechanism behind this association has remained elusive. Here for the first time we show that Gpr151 is a fasting- and glucagon-responsive hepatic gene which regulates hepatic gluconeogenesis. Gpr151 ablation in mice leads to suppression of hepatic gluconeogenesis genes and reduced hepatic glucose production in response to pyruvate. Importantly, the restoration of hepatic Gpr151 levels in the Gpr151 knockout mice reverses the reduced hepatic glucose production. Our findings establish a previously unknown role of Gpr151 in the liver and provides an explanation to the lowered T2D risk in individuals with nonsynonymous mutations in GPR151. This study highlights the therapeutic potential of targeting GPR151 for treatment of metabolic disease.
G protein-coupled receptor 151 regulates glucose metabolism and hepatic gluconeogenesis
Ewa Bielczyk-Maczynska,Meng Zhao,Peter-James H. Zushin,Theresia M. Schnurr,Hyunjae Kim,Jiehan Li,Pratima Nallagatla,Panjamaporn Sangwung,C. Park,Cameron Cornn,Andreas Stahl,Katrin J. Svensson,J. Knowles
Published 2022 in bioRxiv
ABSTRACT
PUBLICATION RECORD
- Publication year
2022
- Venue
bioRxiv
- Publication date
2022-05-28
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-56 of 56 references · Page 1 of 1
CITED BY
Showing 1-11 of 11 citing papers · Page 1 of 1